ArQule (NASDAQ:ARQL) Hits 12-Year High Following Favorable Midstage Study Results

Shares of the small-cap biotech stock ArQule, Inc. (NASDAQ: ARQL) were seeing strength on brisk volume Monday. What Happened Close on the heels of a 30% rally Friday...... Read more on Benzinga


ARQL arqule health-care pharmaceuticals

ContraVir (NASDAQ:CTRV) Moves Higher After NASH Drug Shows 100% Efficacy In Fibrosis Prevention

ContraVir Pharmaceuticals Inc (NASDAQ: CTRV) shares were rallying Monday on positive news related to its non-alcoholic steatohepatitis, or NASH, drug. ContraVir, which came...... Read more on Benzinga


CTRV contravir health-care pharmaceuticals

AKZO NOBEL NV ADR # (AKZOY), (ETCG) - These Were The Most Actively Traded Securities On The OTC Markets In May

Swiss pharmaceutical giant Roche Pharmaceuticals became the first security on OTC Markets to reach $4 billion in dollar trading volume in 2019, according to OTC Markets data...... Read more on Benzinga


VTX:ROG roche-holding health-care pharmaceuticals

What Happened in the Stock Market Today -- The Motley Fool

Acquisitions made headlines, with Pfizer buying Array BioPharma and a private investor picking up Sotheby's.... Read more on The Motley Fool

The Motley Fool

PFE pfizer health-care pharmaceuticals ARRY array-biopharma

Flexion: Finally Looking For An Entry

Flexion Therapeutics recently announced Q1 revenue of only $10.6M but revealed they already had $5.1M in revenue in April. This puts the company on track to hit... Read more on Seeking Alpha

Seeking Alpha

FLXN flexion-therapeutics health-care pharmaceuticals

44 Stocks Moving In Monday’s Mid-Day Session

Gainers Sothebys (NYSE: BID) shares jumped 57.7% to $55.82 after the company announced it will be acquired by BidFair for $57 per share in cash. Array BioPharma Inc. (NASDAQ:...... Read more on Benzinga


ARRY array-biopharma health-care pharmaceuticals

Rockwell Medical slides 23% on new share offering

Rockwell Medical (NASDAQ:RMTI) is 22.9% lower postmarket after launching a share offering. Book-runners are Piper Jaffray and Cantor Fitzgerald. Underwriters will get a 30-day optino to buy up to an... Read more on Seeking Alpha

Seeking Alpha

RMTI rockwell-medical health-care biotechnology

Calithera Biosciences readies secondary offering

Calithera Biosciences (NASDAQ:CALA) announces secondary offering of 10M sharesUnderwriters have an option to purchase up to 1.5M additional sharesPress Release... Read more on Seeking Alpha

Seeking Alpha

CALA calithera-biosciences health-care pharmaceuticals

VBI (NASDAQ:VBIV) Shares Plunge On Mixed Late-Stage Hepatitis B Vaccine Trial Results

VBI Vaccines Inc (NASDAQ: VBIV) shares were in penny stock territory Monday following the release of data from a late-stage study of its hepatitis B virus vaccine candidate....... Read more on Benzinga


VBIV vbi-vaccines health-care biotechnology

Why Iovance Biotherapeutics Stock Jumped Today -- The Motley Fool

Pfizer's acquisition of Array appeared to cause investors to wonder whether a big deal could be in store for Iovance.... Read more on The Motley Fool

The Motley Fool

PFE pfizer health-care pharmaceuticals

Federal Court of Appeal Upholds I-MED Pharma's Patent Win Against TearLab

MONTREAL, June 17, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that the Canadian Federal...... Read more on Benzinga


TEAR tearlab health-care medical/dental-instruments

The Wall Street Journal: Pfizer to buy cancer dug maker Array BioPharma for $10.64 billion

Pfizer Inc. agreed to buy Array BioPharma Inc. for $10.64 billion in cash, as the pharmaceutical company looks to expand its pipeline of cancer therapies.... Read more on MarketWatch


PFE pfizer health-care pharmaceuticals ARRY array-biopharma

Massive Increase In Short Interest Could Be Setting Bears Up For A Fall In Arrowhead Pharmaceuticals

Arrowhead's most recent share price run has left investors wondering if it has run too far too fast. Short interest has risen significantly with the recent run ... Read more on Seeking Alpha

Seeking Alpha

ARWR arrowhead health-care pharmaceuticals

Scynexis And The Fungal Economy

Scynexis is a development stage biotechnology developing a novel antifungal, Ibrexafungerp, with a high probability of success. Although a competitive landscape... Read more on Seeking Alpha

Seeking Alpha

SCYX scynexis health-care pharmaceuticals

Pfizer makes $10.6 billion cancer bet in cash deal for Array Biopharma

Pfizer Inc on Monday said it would buy Array Biopharma Inc for $10.64 billion in cash, a deal it hopes will help make it a leader in colon cancer and build up its pipeline of oncology drugs.... Read more on Reuters


PFE pfizer health-care pharmaceuticals ARRY array-biopharma

Aclaris Announces Positive Results From Alopecia Treatment Trial (NASDAQ:ACRS)

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced positive six-month results from a Phase 2 clinical trial of ATI-502 for patients with androgenetic alopecia. The trial...... Read more on Benzinga


ACRS aclaris-therapeutics health-care pharmaceuticals

Here's Why ArQule Is Soaring Again Today -- The Motley Fool

A new day, a new batch of promising interim data from an early-stage clinical study.... Read more on The Motley Fool

The Motley Fool

ARQL arqule health-care pharmaceuticals